Merck Sharp & Dohme LLC Recall: Merck Emend (aprepitant) for oral suspension, 125 mg, Sing
Merck Sharp & Dohme LLC Recall: Merck Emend (aprepitant) for oral suspension, 125 mg, Sing is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Merck Sharp & Dohme LLC; Product: Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe &
| Recalling firm | Merck Sharp & Dohme LLC |
|---|---|
| Product | Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03 |
| Reason for recall | Presence of particulate matter: potential presence of metal particulates in the product. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | Nationwide in the USA |
| Recall initiated | 20251212 |
| Recall number | D-0241-2026 |
| Category | drug |
| State | NC |
| Country | United States |
$29/mo
Try RecallGuard →